Member Directory

Below all members are listed in alphabetical order. Click the tabs above to view working group members.

Dr. Abrams is a Professor of Epidemiology and Pediatrics at Columbia University and Senior Director for Research at ICAP.

Conflict of Interest: No real or apparent conflicts of interest to report.

Nicole Ammerman is a Research Associate in the Department of Medicine, Division of Infectious Diseases, at the Johns Hopkins University School of Medicine. 

Conflict of Interest:  No real or apparent conflicts of interest to report.

Terrence F. Blaschke, MD, is Professor of Medicine and Molecular Pharmacology (Emeritus) at Stanford University.

Conflict of Interest: Dr. Blaschke has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Durect Corporation, Cupertino California

Dr. Bollinger is Founding Director of the Center for Clinical Global Health Education (CCGHE) and Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine.

Conflict of Interest: I am a member of a Data Monitoring Committee for Merck & Co.

Richard E. Chaisson, MD, is Professor of Medicine, Epidemiology, and International Health at Johns Hopkins University and Director of the Johns Hopkins Center for TB Research and the Center for AIDS Research.

Conflict of Interest: My spouse owns stock in Merck.  I have consulted for Sanofi.

Polly Clayden has been working as an advocate and activist for over 12 years and co-founded i-Base in April 2000

Conflict of Interest: No real or apparent conflicts of interest to report.

Daniel E Cohen, MD, is a Group Medical Director in Clinical Development at AbbVie.

Conflict of Interest: Dr. Cohen is an employee and stockholder of AbbVie.

Dr. Paul L. Domanico holds a PhD in Chemistry and a Bachelor of Science degree in Pre-Medicine from Penn State University. He received his post-doctoral training in Molecular Biophysics at E.I. du Pont de Nemours and Co.

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Dr. Feld attended medical school at the University of Toronto and then completed residency programs in Internal Medicine and Gastroenterology.

Conflicts of Interest: Dr. Jordan Feld received Personal fees for scientific consulting from: Abbott, Abbvie, Gilead, Enanta, Roche. Dr. Feld reports receiving grants for research from Abbvie, Gilead, Janssen, Wako/Fujifilm 

Charles W. Flexner, MD, is the Principal Investigator of the Long Acting/Extended Release Antiretroviral Resource Program (LEAP).

Conflict of Interest: Dr. Flexner has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Algernon Pharmaceuticals; Gilead; Merck; Mylan Pharmaceuticals; ViiV Healthcare. 

Lobna Gaayeb manages the Long-Acting Technologies project at the Medicines Patent Pool. She has experience in coordinating international networks and scientific projects.

Conflict of Interest:  I have no real or apparent conflicts of interest to report.

Daria Hazuda, PhD, trained as a biochemist at the State University of New York at Stony Brook, N.Y.

Conflict of Interest: None disclosed.

Magali Hickey is the Director of Formulation Development at Alkermes Inc.

Conflict of Interest: None disclosed.

Dr. Rodney JY Ho is a distinguished professor of pharmaceutics (SOP), adjunct professor of bioengineering (SOM) and is an inaugural presidential entrepreneurial fellow of the University of Washington. 

Conflict of Interest: No disclosures.

Jeffrey M. Jacobson, MD is Professor of Medicine at Case Western Reserve University and Principal Investigator of the Case AIDS Clinical Trials Unit. 

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Leah Johnson, PhD, is a Senior Research Chemist in the Center for Engineered Systems at RTI International.

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Andy Kaytes has been an active member and currently co-chairs the Community Advisory Board at the University of California San Diego’s Antiviral Research Center since 2004.

Conflict of Interest: Andy has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Bristol Myers Squibb

Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School. 

Conflict of Interest: I have received research support from Gilead, Merck, Novartis and ViiV. I also serve as a consultant to Atea, Gilead, GSK, Merck and ViiV.

Mila Maistat works as Policy and Advocacy Manager with the Medicines Patent Pool (MPP). She has almost 20 years of experience of working in public health, in particular, viral hepatitis and HIV policy, advocacy and access to medicines. 

Conflict of Interest:  No real or apparent conflict of interest to report.

Craig McClure leads the Viral Hepatitis Program at the Clinton Health Access Initiative (CHAI).

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Ms. McKenzie-White is Managing Director and Senior Program Officer at the Center for Clinical Global Health Education.

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Mark Mirochnick, M.D. is Professor of Pediatrics and a member of the Division of Neonatology at Boston University School of Medicine/Boston Medical Center.

Conflict of Interest: Dr. Mirochnick has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Merck, ViiV, Gilead, ReViral.

Dr. Nuermberger is an Associate Professor of Medicine and International Health at Johns Hopkins University. His primary research interest is the experimental chemotherapy of TB.

Conflict of Interest:  I have research grants and contracts from Janssen, TB Alliance and the Gates Medical Research Institute in addition to NIH.

David has >20 years of infectious disease drug discovery experience with a focus on HIV-1 and HCV.

Conflict of Interest: 

Andrew Owen is a Professor in the Department of Molecular and Clinical Pharmacology at the University of Liverpool. 

Conflict of Interest: Dr. Owen has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Merck; GSK; Janssen; ViiV Healthcare

Dr. Chuck Peloquin received his BS in Pharmacy from the University of Connecticut and his Doctor of Pharmacy from the Philadelphia College of Pharmacy and Science.

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Pharmaceutical Advocate to Médecins Sans Frontières on specific dossiers, such as access to Tuberculosis medicines.

Conflict of Interest: No real or apparent conflicts of interest to report.

Manuele Piccolis holds a PhD in Life Sciences from the University of Geneva and he has an extensive experience in metabolism.

Conflict of Interest: No disclosures

Dr. Podany is currently an Assistant Professor in the department of pharmacy practice at the University of Nebraska Medical Center.

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Dr. Rangaka is an Associate Professor within the Institute of Global Health, University College London (UCL), United Kingdom.

Conflict of Interest: No real or apparent conflicts of interest to report.

Bart Remmerie, Chem. Eng., graduated as a bio-engineer and as environmental engineer at Ghent University, Belgium. He started at Janssen (Bioanalysis) in 1994.

Conflict of Interest: As a Janssen employee I have a wage and shares from/in the company.

Dr. James F. Rooney joined Gilead Sciences in 1996 as Vice President of Clinical Research and in 2004 became Vice President of Medical Affairs.

Conflict of Interest: None disclosed.

Kimberly Scarsi is an Associate Professor at the University of Nebraska Medical Center’s (UNMC) College of Pharmacy.

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Dr Marco Siccardi graduated with an MSc in Clinical Biology (2006) at the University of Turin, Italy. 

Conflict of Interest: I received research grants from Janssen and ViiV. I also serve as a consultant to Merck, Resolution Therapeutics and Nevakar Inc.

Leonard A Sowah, MBChB, MPH, is a medical officer at the Division of AIDS in the Complications and Coinfections Research Branch.

Conflict of Interest: I have no disclosures to declare.

Bill Spreen, Pharm.D, is a Director of Research and Development at ViiV Healthcare and based in Research Triangle Park, North Carolina.

Conflict of Interest: None disclosed.

Kimberly Struble, PharmD, is a Senior Clinical Team Leader in the Division of Antiviral Products at the Food and Drug Administration. 

Conflict of Interest: None disclosed.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases Johns Hopkins Bayview Medical Center.

Conflict of Interest: I have no real or apparent conflicts of interest to report.

Susan Swindells is a Professor of Internal Medicine in the Section of Infectious Diseases at the University of Nebraska Medical Center, USA.

Conflict of Interest: Dr. Swindells reports research grants to her institution from ViiV Healthcare.

Dr. Norah Terrault is Professor of Medicine and Chief of Gastroenterology and Liver Diseases at the Keck School of Medicine at University of Southern California.

Conflict of Interest: Dr. Terrault has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Gilead, CCO Hepatitis, Allergan Pharmaceuticals, Dova Pharmaceuticals, Intercept, EXIGO Management Consultants, LLC, Genetech & Roche.

David Thomas is Director of Infectious Diseases and the Stanhope Bayne-Jones Professor of Medicine at the Johns Hopkins School of Medicine.

Conflict of Interest: I have no real or apparent conflicts of interest to report.